SYMATESE Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 400

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 3

  • Investments
  • 1

SYMATESE General Information

Description

Manufacturer of collagen raw material products intended for medical, pharmaceutical and cosmetics sector companies. The company offers customized collagen, hyaluronate crosslinking platforms, hemotese and other such biopolymers for related medical devices through its research and development activities.

Contact Information

Website
www.symatese.com
Formerly Known As
SYMATESE Biomatériaux
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • Z.I. Les Troques
  • 69630 Chaponost
  • France
+33 04
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Z.I. Les Troques
  • 69630 Chaponost
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SYMATESE Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SYMATESE‘s full profile, request access.

Request a free trial

SYMATESE Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of collagen raw material products intended for medical, pharmaceutical and cosmetics sector companies. The
Biotechnology
Chaponost, France
400 As of 2025

Minatoku, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SYMATESE Competitors (1)

One of SYMATESE’s competitors is Kikkoman Biochemifa Company, a Corporation company based in Minatoku, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kikkoman Biochemifa Company Corporation Minatoku, Japan
You’re viewing 1 of 1 competitors. Get the full list »

SYMATESE Patents

  • 49

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

SYMATESE Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022228664-A1 Implantable or injectable products based on polymers and method for their preparation Pending 02-Mar-2021
CA-3208406-A1 Implantable or injectable products based on polymers and method for their preparation Pending 02-Mar-2021
EP-4301428-A1 Implantable or injectable products based on polymers and method for their preparation Pending 02-Mar-2021
US-20240189428-A1 Implantable or injectable products based on polymers and method for their preparation Pending 02-Mar-2021
WO-2022184775-A1 Implantable or injectable products based on polymers and method for their preparation Inactive 02-Mar-2021 A61L27/26
To view SYMATESE’s complete patent history, request access »

SYMATESE Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SYMATESE Investments (1)

SYMATESE’s most recent deal was a Buyout/LBO with Symatese Device. The deal was made on 01-Jan-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Symatese Device 01-Jan-2014 Buyout/LBO Medical Supplies
To view SYMATESE’s complete investments history, request access »

SYMATESE FAQs

  • When was SYMATESE founded?

    SYMATESE was founded in 1997.

  • Where is SYMATESE headquartered?

    SYMATESE is headquartered in Chaponost, France.

  • What is the size of SYMATESE?

    SYMATESE has 400 total employees.

  • What industry is SYMATESE in?

    SYMATESE’s primary industry is Biotechnology.

  • Is SYMATESE a private or public company?

    SYMATESE is a Private company.

  • What is SYMATESE’s current revenue?

    The current revenue for SYMATESE is .

  • Who are SYMATESE’s competitors?

    Kikkoman Biochemifa Company is a competitor of SYMATESE.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process